6 results
8-K
EX-99.1
IVVD
Invivyd Inc
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
identifier, age or date of birth, sex, weight, ethnicity, and race).
A statement “PEMGARDA use for the pre-exposure prophylaxis of COVID-19 under Emergency
8-K
EX-99.3
IVVD
Invivyd Inc
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
., patient identifier, age or date of birth, sex, weight, ethnicity, and race). Pre-exposure prophylaxis with PEMGARDA is not a substitute
8-K
EX-99.1
IVVD
Invivyd Inc
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
of birth, sex, weight, ethnicity, and race).
A statement “PEMGARDA use for the pre-exposure prophylaxis of COVID-19 under Emergency Use Authorization (EUA
PRE 14A
IVVD
Invivyd Inc
31 Mar 23
Preliminary proxy
4:36pm
or Ethnicity
Did Not Disclose LGBTQ+ Status
Independence of the Board
As required under The Nasdaq Stock Market LLC (“Nasdaq”) listing standards … of diversity and inclusion and, accordingly, in conducting this assessment, our Board considers diversity of race, ethnicity, gender, age, education
DEF 14A
hi2837ndg o1vqeghqa
10 Apr 23
Definitive proxy
4:07pm
- Prev
- 1
- Next